Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers.

Thompson JH, Schneider JL, Rivelli JS, Petrik AF, Vollmer WM, Fuoco MJ, Coronado GD.

J Prim Care Community Health. 2019 Jan-Dec;10:2150132719890950. doi: 10.1177/2150132719890950.

PMID:
31779517
2.

Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.

Coronado GD, Green BB, West II, Schwartz MR, Coury JK, Vollmer WM, Shapiro JA, Petrik AF, Baldwin LM.

Cancer. 2019 Oct 28. doi: 10.1002/cncr.32567. [Epub ahead of print]

PMID:
31658375
3.

Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithiasis Guideline Panel.

Donaldson JF, Ruhayel Y, Skolarikos A, MacLennan S, Yuan Y, Shepherd R, Thomas K, Seitz C, Petrik A, Türk C, Neisius A.

Eur Urol. 2019 Sep;76(3):352-367. doi: 10.1016/j.eururo.2019.06.018. Epub 2019 Jul 13. Review.

PMID:
31311676
4.

Challenges in assessing population reach in a pragmatic trial.

Green BB, Vollmer WM, Keast E, Petrik AF, Coronado GD.

Prev Med Rep. 2019 May 29;15:100910. doi: 10.1016/j.pmedr.2019.100910. eCollection 2019 Sep.

5.

Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.

Coronado GD, Thompson JH, Petrik AF, Nyongesa DB, Leo MC, Castillo M, Younger B, Escaron A, Chen A.

J Am Board Fam Med. 2019 May-Jun;32(3):318-328. doi: 10.3122/jabfm.2019.03.180275.

6.

A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics.

Meenan RT, Coronado GD, Petrik A, Green BB.

Prev Med. 2019 Mar;120:119-125. doi: 10.1016/j.ypmed.2019.01.014. Epub 2019 Jan 24.

PMID:
30685318
7.

Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.

Nielson CM, Vollmer WM, Petrik AF, Keast EM, Green BB, Coronado GD.

J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25.

PMID:
30684199
8.

A randomized, pragmatic, pharmacist-led intervention reduced opioids following orthopedic surgery.

Smith DH, Kuntz JL, DeBar LL, Mesa J, Yang X, Schneider J, Petrik A, Reese K, Thorsness LA, Boardman D, Johnson ES.

Am J Manag Care. 2018 Nov;24(11):515-521.

9.

Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.

Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD.

Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby094. [Epub ahead of print]

PMID:
30445511
10.

Effectiveness of automated and live phone reminders after mailed-FIT outreach in a pilot randomized trial.

Nielson CM, Rivelli JS, Fuoco MJ, Gawlik VR, Jimenez R, Petrik AF, Coronado GD.

Prev Med Rep. 2018 Oct 17;12:210-213. doi: 10.1016/j.pmedr.2018.10.012. eCollection 2018 Dec.

11.

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.

Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, Rivelli JS, Kapka TJ, Meenan RT, Mummadi RR, Green BB, Coronado GD.

Cancer Med. 2018 Sep;7(9):4781-4790. doi: 10.1002/cam4.1727. Epub 2018 Aug 13.

12.

Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.

Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB.

JAMA Intern Med. 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629. Erratum in: JAMA Intern Med. 2019 Jul 1;179(7):1007.

13.

Spatial relationship between the field-measured ambient gamma dose equivalent rate and geological conditions in a granitic area, Velence Hills, Hungary: An application of digital spatial analysis methods.

Torres SB, Petrik A, Szabó KZ, Jordan G, Yao J, Szabó C.

J Environ Radioact. 2018 Dec;192:267-278. doi: 10.1016/j.jenvrad.2018.07.001. Epub 2018 Jul 7.

PMID:
29990774
14.

Status, sources and contamination levels of organochlorine pesticide residues in urban and agricultural areas: a preliminary review in central-southern Italian soils.

Thiombane M, Petrik A, Di Bonito M, Albanese S, Zuzolo D, Cicchella D, Lima A, Qu C, Qi S, De Vivo B.

Environ Sci Pollut Res Int. 2018 Sep;25(26):26361-26382. doi: 10.1007/s11356-018-2688-5. Epub 2018 Jul 6.

PMID:
29981022
15.

Mapping Multi-Site Clinic Workflows to Design Systems-Enabled Interventions.

Coronado GD, Retecki S, Petrik AF, Coury J, Aguirre J, Taplin SH, Burdick T, Green BB.

EGEMS (Wash DC). 2017 Jun 14;5(1):13. doi: 10.5334/egems.219.

16.

Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial.

Thompson JH, Davis MM, Leo MC, Schneider JL, Smith DH, Petrik AF, Castillo M, Younger B, Coronado GD.

Contemp Clin Trials. 2018 Apr;67:11-15. doi: 10.1016/j.cct.2018.02.001. Epub 2018 Feb 9.

17.

Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.

Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, Barker S, Topalanchik E, Jimenez R.

J Gen Intern Med. 2018 Jan;33(1):72-78. doi: 10.1007/s11606-017-4184-x. Epub 2017 Oct 10.

18.

Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers.

Petrik AF, Le T, Keast E, Rivelli J, Bigler K, Green B, Vollmer WM, Coronado G.

J Community Health. 2018 Feb;43(1):128-136. doi: 10.1007/s10900-017-0395-7.

19.

Grey Zones in Urolithiasis Guidelines.

Türk C, Knoll T, Petřík A, Sarica K, Seitz C, Skolarikos A.

Eur Urol Focus. 2017 Feb;3(1):144-146. doi: 10.1016/j.euf.2017.01.013. Epub 2017 Feb 9. No abstract available.

PMID:
28720361
20.

Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.

Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, Taplin SH, Green BB, Coronado GD.

BMC Health Serv Res. 2017 Jun 19;17(1):411. doi: 10.1186/s12913-017-2364-3.

21.

What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review.

Drake T, Grivas N, Dabestani S, Knoll T, Lam T, Maclennan S, Petrik A, Skolarikos A, Straub M, Tuerk C, Yuan CY, Sarica K.

Eur Urol. 2017 Nov;72(5):772-786. doi: 10.1016/j.eururo.2017.04.016. Epub 2017 Apr 26. Review.

PMID:
28456350
22.

Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel.

Ruhayel Y, Tepeler A, Dabestani S, MacLennan S, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Türk C, Yuan Y, Knoll T.

Eur Urol. 2017 Aug;72(2):220-235. doi: 10.1016/j.eururo.2017.01.046. Epub 2017 Feb 23. Review.

PMID:
28237786
23.

Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders.

Coronado GD, Schneider JL, Petrik A, Rivelli J, Taplin S, Green BB.

Transl Behav Med. 2017 Sep;7(3):557-566. doi: 10.1007/s13142-016-0461-1.

24.

Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.

Schroeder EB, Yang X, Thorp ML, Arnold BM, Tabano DC, Petrik AF, Smith DH, Platt RW, Johnson ES.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):87-94. doi: 10.2215/CJN.01290216. Epub 2016 Dec 27.

25.

Spatial analysis of ambient gamma dose equivalent rate data by means of digital image processing techniques.

Szabó KZ, Jordan G, Petrik A, Horváth Á, Szabó C.

J Environ Radioact. 2017 Jan;166(Pt 2):309-320. doi: 10.1016/j.jenvrad.2016.07.013. Epub 2016 Aug 1.

PMID:
27491859
26.

The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics.

Petrik AF, Green BB, Vollmer WM, Le T, Bachman B, Keast E, Rivelli J, Coronado GD.

Fam Pract. 2016 Dec;33(6):639-643. Epub 2016 Jul 28.

27.

Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.

Oluloro A, Petrik AF, Turner A, Kapka T, Rivelli J, Carney PA, Saha S, Coronado GD.

J Community Health. 2016 Aug;41(4):864-70. doi: 10.1007/s10900-016-0165-y.

28.

Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.

Kuntz JL, Smith DH, Petrik AF, Yang X, Thorp ML, Barton T, Barton K, Labreche M, Spindel SJ, Johnson ES.

Perm J. 2016 Winter;20(1):20-5. doi: 10.7812/TPP/15-049.

29.

EAU Guidelines on Interventional Treatment for Urolithiasis.

Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T.

Eur Urol. 2016 Mar;69(3):475-82. doi: 10.1016/j.eururo.2015.07.041. Epub 2015 Sep 4. Review.

PMID:
26344917
30.

EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis.

Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T.

Eur Urol. 2016 Mar;69(3):468-74. doi: 10.1016/j.eururo.2015.07.040. Epub 2015 Aug 28. Review.

PMID:
26318710
31.

Systolic BP and Mortality in Older Adults with CKD.

Weiss JW, Peters D, Yang X, Petrik A, Smith DH, Johnson ES, Thorp ML, Morris C, O'Hare AM.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1553-9. doi: 10.2215/CJN.11391114. Epub 2015 Aug 14.

32.

Predicting mortality in older adults with kidney disease: a pragmatic prediction model.

Weiss JW, Platt RW, Thorp ML, Yang X, Smith DH, Petrik A, Eckstrom E, Morris C, O'Hare AM, Johnson ES.

J Am Geriatr Soc. 2015 Mar;63(3):508-15. doi: 10.1111/jgs.13257. Epub 2015 Mar 4.

33.

Reasons for non-response to a direct-mailed FIT kit program: lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center.

Coronado GD, Schneider JL, Sanchez JJ, Petrik AF, Green B.

Transl Behav Med. 2015 Mar;5(1):60-7. doi: 10.1007/s13142-014-0276-x.

34.

Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score.

Kuntz JL, Johnson ES, Raebel MA, Platt RW, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Clin Microbiol Infect. 2015 Mar;21(3):256-62. doi: 10.1016/j.cmi.2014.11.001. Epub 2014 Nov 11.

35.

Health Policy to Promote Colorectal Cancer Screening: Improving Access and Aligning Federal and State Incentives.

Coronado GD, Petrik AF, Bartelmann SE, Coyner LA, Coury J.

Clin Res (Alex). 2015 Feb;29(1):50-55. Epub 2015 Feb 1.

36.

Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.

Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C.

Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.

PMID:
25454613
37.

Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study.

Coronado GD, Burdick T, Petrik A, Kapka T, Retecki S, Green B.

J Gen Pract (Los Angel). 2014 Jan 5;2. pii: 1000141.

38.

A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line.

Kirshenbaum AS, Petrik A, Walsh R, Kirby TL, Vepa S, Wangsa D, Ried T, Metcalfe DD.

Int Arch Allergy Immunol. 2014;164(4):265-70. doi: 10.1159/000365729. Epub 2014 Sep 3.

39.

Clinical perspectives on colorectal cancer screening at Latino-serving federally qualified health centers.

Coronado GD, Petrik AF, Spofford M, Talbot J, Do HH, Taylor VM.

Health Educ Behav. 2015 Feb;42(1):26-31. doi: 10.1177/1090198114537061. Epub 2014 Jun 20.

40.

Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.

Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB.

Contemp Clin Trials. 2014 Jul;38(2):344-9. doi: 10.1016/j.cct.2014.06.006. Epub 2014 Jun 14.

41.

Individuality of the plasma sodium concentration.

Zhang Z, Duckart J, Slatore CG, Fu Y, Petrik AF, Thorp ML, Cohen DM.

Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1534-43. doi: 10.1152/ajprenal.00585.2013. Epub 2014 Apr 9.

42.

Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes.

Coronado GD, Vollmer WM, Petrik A, Aguirre J, Kapka T, Devoe J, Puro J, Miers T, Lembach J, Turner A, Sanchez J, Retecki S, Nelson C, Green B.

BMC Cancer. 2014 Feb 26;14:55. doi: 10.1186/1471-2407-14-55.

43.

Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center.

Coronado GD, Sanchez J, Petrik A, Kapka T, DeVoe J, Green B.

J Cancer Educ. 2014 Mar;29(1):86-90. doi: 10.1007/s13187-013-0551-4.

44.

Distinguishing integrative from eclectic practice in cognitive behavioral therapies.

Petrik AM, Kazantzis N, Hofmann SG.

Psychotherapy (Chic). 2013 Sep;50(3):392-7. doi: 10.1037/a0032412.

PMID:
24000858
45.

Perceptions of under and overutilization of cervical cancer screening services at Latino-serving community health centers.

Coronado GD, Petrik A, Spofford M, Talbot J, Do HH, Sanchez J, Kapka T, Taylor V.

J Community Health. 2013 Oct;38(5):915-8. doi: 10.1007/s10900-013-9701-1.

PMID:
23728821
46.

Should measuring haemoglobin among chronic kidney disease patients be a performance measure?

Thorp ML, Smith DH, Johnson ES, Weiss JW, Vupputuri S, Petrik AF, Yang XH.

J Evid Based Med. 2012 Nov;5(4):194-204. doi: 10.1111/jebm.12005.

PMID:
23557499
47.

Prescription opioids for back pain and use of medications for erectile dysfunction.

Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, Petrik A, Morasco BJ, Dobscha SK.

Spine (Phila Pa 1976). 2013 May 15;38(11):909-15. doi: 10.1097/BRS.0b013e3182830482.

48.

Predicting costs of care in heart failure patients.

Smith DH, Johnson ES, Blough DK, Thorp ML, Yang X, Petrik AF, Crispell KA.

BMC Health Serv Res. 2012 Nov 30;12:434. doi: 10.1186/1472-6963-12-434.

49.

Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative study.

Smith DH, Schneider J, Thorp ML, Vupputuri S, Weiss JW, Johnson ES, Feldstein A, Petrik AF, Yang X, Snyder SR.

BMC Nephrol. 2012 Nov 23;13:154. doi: 10.1186/1471-2369-13-154.

50.

Correlates of higher-dose opioid medication use for low back pain in primary care.

Kobus AM, Smith DH, Morasco BJ, Johnson ES, Yang X, Petrik AF, Deyo RA.

J Pain. 2012 Nov;13(11):1131-8. doi: 10.1016/j.jpain.2012.09.003.

Supplemental Content

Loading ...
Support Center